Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

Jan P. Nicolay, Susanne Melchers, Jana D. Albrecht, Chalid Assaf, Edgar Dippel, Rudolf Stadler, Ulrike Wehkamp, Marion Wobser, Jing Zhao, Ina Burghaus, Sven Schneider, Karsten Gülow, Sergij Goerdt, Christian M. Schürch, Jochen S. Utikal, Peter H. Krammer

Blood (2023) 142 (9): 794–805.

https://doi.org/10.1182/blood.2022018669

Published: 2023

Includes: Supplemental data

Journal Articles

Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma

Tabea C. Froehlich, Karin Müller-Decker, Jana D. Braun, Thomas Albrecht, Anne Schroeder, Karsten Gülow, Sergij Goerdt, Peter H. Krammer, Jan P. Nicolay

Blood (2019) 134 (5): 445–455.

https://doi.org/10.1182/blood.2019001545

Published: 2019

Includes: Supplemental data

Journal Articles

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB

Jan P. Nicolay, Karin Müller-Decker, Anne Schroeder, Markus Brechmann, Markus Möbs, Cyrill Géraud, Chalid Assaf, Sergij Goerdt, Peter H. Krammer, Karsten Gülow

Blood (2016) 128 (6): 805–815.

https://doi.org/10.1182/blood-2016-01-694117

Published: 2016

Includes: Supplemental data

Journal Articles

The Proliferation Inhibitor CDKN1C (P57KIP2) Is Over Expressed in CD34+ Cells of Patients with MDS and Determines a Worse Prognosis Independently of IPSS Score Factors

Sascha Dietrich, MD, Mindaugas Andrulis, MD, Andrea Pellagatti, PhD, Aleksandar Radujkovic, MD, Ulrich Germing, MD, Stephan Baldus, MD, Thomas Giese, MD, Jacqueline Boultwood, MD, Peter H Krammer, PhD, Peter Dreger, MD, Anthony D. Ho, MD, Thomas Luft, MD

Blood (2012) 120 (21): 3820.

https://doi.org/10.1182/blood.V120.21.3820.3820

Published: 2012

Journal Articles

Inhibition of Antibody Production in Vitro with Bispecific CD20 X CD95 Antibodies

Kristina Nalivaiko, Martin Hofmann, Ludger Grosse-Hovest, Peter H Krammer, Hans-Georg Rammensee, Helmut R. Salih, MD, Gundram Jung

Blood (2011) 118 (21): 1114.

https://doi.org/10.1182/blood.V118.21.1114.1114

Published: 2011

Journal Articles

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade

Michael K. Kießling, Patrick A. Oberholzer, Chandrani Mondal, Maria B. Karpova, Marie C. Zipser, William M. Lin, Michael Girardi, Laura E. MacConaill, Sarah M. Kehoe, Charlie Hatton, Lars E. French, Levi A. Garraway, Gernot Polier, Dorothee Süss, Claus-Detlev Klemke, Peter H. Krammer, Karsten Gülow, Reinhard Dummer

Blood (2011) 117 (8): 2433–2440.

https://doi.org/10.1182/blood-2010-09-305128

Published: 2011

Includes: Supplemental data

Journal Articles

Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca 2+ -dependent apoptosis

Sven Baumann, Stefanie C. Fas, Marco Giaisi, Wolfgang W. Müller, Anette Merling, Karsten Gülow, Lutz Edler, Peter H. Krammer, Min Li-Weber

Blood (2008) 111 (4): 2354–2363.

https://doi.org/10.1182/blood-2007-06-096198

Published: 2008

Journal Articles

Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes

Dirk Brenner, Alexander Golks, Mareike Becker, Wolfgang Müller, Christian R. Frey, Rostislav Novak, Doron Melamed, Friedemann Kiefer, Peter H. Krammer, Rüdiger Arnold

Blood (2007) 110 (12): 3968–3977.

https://doi.org/10.1182/blood-2007-01-071167

Published: 2007

Includes: Supplemental data

Journal Articles

Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis

Stefanie C. Fas, Sven Baumann, Jia Yun Zhu, Marco Giaisi, Monika K. Treiber, Ulrich Mahlknecht, Peter H. Krammer, Min Li-Weber

Blood (2006) 108 (12): 3700–3706.

https://doi.org/10.1182/blood-2006-03-011973

Published: 2006

Journal Articles

Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis

Inna N. Lavrik, Alexander Golks, Simone Baumann, Peter H. Krammer

Blood (2006) 108 (2): 559–565.

https://doi.org/10.1182/blood-2005-07-007096

Published: 2006

Journal Articles

HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)

Andreas Krueger, Stefanie C. Fas, Marco Giaisi, Marc Bleumink, Anette Merling, Christine Stumpf, Sven Baumann, Denise Holtkotte, Valerie Bosch, Peter H. Krammer, Min Li-Weber

Blood (2006) 107 (10): 3933–3939.

https://doi.org/10.1182/blood-2005-06-2567

Published: 2006

Includes: Supplemental data

Journal Articles

Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer

Sven Baumann, Anja Dostert, Natalia Novac, Anton Bauer, Wolfgang Schmid, Stefanie C. Fas, Andreas Krueger, Thorsten Heinzel, Sabine Kirchhoff, Günther Schütz, Peter H. Krammer

Blood (2005) 106 (2): 617–625.

https://doi.org/10.1182/blood-2004-11-4390

Published: 2005

Journal Articles

Expression of c-FLIP L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide

Fabienne Willems, Zoulikha Amraoui, Nathalie Vanderheyde, Valérie Verhasselt, Ezra Aksoy, Carsten Scaffidi, Marcus E. Peter, Peter H. Krammer, Michel Goldman

Blood (2000) 95 (11): 3478–3482.

https://doi.org/10.1182/blood.V95.11.3478

Published: 2000

Journal Articles

Caspase Activation Is Required for Nitric Oxide–Mediated, CD95(APO-1/Fas)–Dependent and Independent Apoptosis in Human Neoplastic Lymphoid Cells

Katerina Chlichlia, Marcus E. Peter, Marian Rocha, Carsten Scaffidi, Mariana Bucur, Peter H. Krammer, Volker Schirrmacher, Victor Umansky

Blood (1998) 91 (11): 4311–4320.

https://doi.org/10.1182/blood.V91.11.4311

Published: 1998

NARROW

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB

The Proliferation Inhibitor CDKN1C (P57KIP2) Is Over Expressed in CD34+ Cells of Patients with MDS and Determines a Worse Prognosis Independently of IPSS Score Factors

Inhibition of Antibody Production in Vitro with Bispecific CD20 X CD95 Antibodies

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade

Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca 2+ -dependent apoptosis

Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes

Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis

Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis

HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)

Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer

Expression of c-FLIP L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide

Caspase Activation Is Required for Nitric Oxide–Mediated, CD95(APO-1/Fas)–Dependent and Independent Apoptosis in Human Neoplastic Lymphoid Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only